Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longeveron Inc.LGVN · Entity 7608 | Director | December 21, 2022 | December 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longeveron Inc.
Report date December 21, 2022 · Filed December 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2032-12-21 | Direct | 5,000 |
Reported balance
After 2022-12-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-12-21 · Grant · Acquired 5,000 · Balance 5,000 F1: The option vests in four equal annual installments beginning on first anniversary of date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal annual installments beginning on first anniversary of date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 21, 2022 Filed Dec 22, 2022 23:00 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (Right to buy) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001214659-22-015250 · marketforms-57930.xml · derivative · entry 1 Soffer Donald M · CIK 0001845860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-12-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant. Read SEC document |
| May 17, 2022 Filed May 19, 2022 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | OtherCommon Stock | 6,535,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007228 · marketforms-56222.xml · nonDerivative · entry 2 Soffer Donald M · CIK 0001845860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,693,737 F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. F3 · price: Shares received as part of pro rata distribution by DS Med, LLC, to its members for no consideration. F4 · balance_after: Amount includes 6,535,223 shares of Class B Common Stock. Read SEC document |
| May 17, 2022 Filed May 19, 2022 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | OtherCommon Stock | 7,024,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007228 · marketforms-56222.xml · nonDerivative · entry 1 Soffer Donald M · CIK 0001845860 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by affiliate entity Disclosed balance after: 0 F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. F2 · price: Shares distributed on pro rated basis to members of DS Med, LLC, for no consideration. Read SEC document |
| April 13, 2022 Filed Apr 18, 2022 21:00 UTC | Longeveron Inc. LGVN · Entity 7608 | OtherCommon Stock | 748,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-005396 · marketforms-55982.xml · nonDerivative · entry 1 Soffer Donald M · CIK 0001845860 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by affiliated entity Disclosed balance after: 7,024,208 F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. F3 · shares: Shares held by affiliated entity, for which reporting person disclaims beneficial ownership except to the extent of his pecuniary interest. F2 · price: Shares distributed to members of DS Med, LLC, for no consideration. F1 · balance_after: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. F3 · balance_after: Shares held by affiliated entity, for which reporting person disclaims beneficial ownership except to the extent of his pecuniary interest. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:11 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-026420 · ownership.xml · nonDerivative · entry 1 Soffer Donald M · CIK 0001845860 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,514 F1 · shares: Restricted Stock units subject to time-based vesting requirements. F2 · balance_after: Includes 58,514 Restricted Stock Units. Read SEC document |
| February 12, 2021 Filed Feb 26, 2021 23:00 UTC | Longeveron Inc. LGVN · Entity 7608 | PurchaseCommon Stock | 100,000 | $10.00 | $1,000,000.00 |
DisclosureSEC source: 0001214659-21-002446 · marketforms-51653.xml · nonDerivative · entry 1 Soffer Donald M · CIK 0001845860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,514 F1 · balance_after: Includes 53,514 Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.